168 related articles for article (PubMed ID: 7785428)
1. Regional cerebral glucose metabolism in autopsy-confirmed Creutzfeldt-Jakob disease.
Matochik JA; Molchan SE; Zametkin AJ; Warden DL; Sunderland T; Cohen RM
Acta Neurol Scand; 1995 Feb; 91(2):153-7. PubMed ID: 7785428
[TBL] [Abstract][Full Text] [Related]
2. Serial positron emission tomography with fludeoxyglucose F 18 in Creutzfeldt-Jakob disease.
Ogawa T; Inugami A; Fujita H; Hatazawa J; Shimosegawa E; Kanno I; Okudera T; Uemura K; Nagata K
AJNR Am J Neuroradiol; 1995 Apr; 16(4 Suppl):978-81. PubMed ID: 7611090
[TBL] [Abstract][Full Text] [Related]
3. Bitemporal hypometabolism in Creutzfeldt-Jakob disease measured by positron emission tomography with [18F]-2-fluorodeoxyglucose.
Friedland RP; Prusiner SB; Jagust WJ; Budinger TF; Davis RL
J Comput Assist Tomogr; 1984 Oct; 8(5):978-81. PubMed ID: 6381559
[TBL] [Abstract][Full Text] [Related]
4. Positron emission tomography and histopathology in Creutzfeldt-Jakob disease.
Goldman S; Laird A; Flament-Durand J; Luxen A; Bidaut LM; Stanus E; Hildebrand J; Przedborski S
Neurology; 1993 Sep; 43(9):1828-30. PubMed ID: 8414042
[TBL] [Abstract][Full Text] [Related]
5. Positron emission tomography with [(18)F]FDG in the diagnosis of Creutzfeldt-Jakob disease (CJD).
Henkel K; Zerr I; Hertel A; Gratz KF; Schröter A; Tschampa HJ; Bihl H; Büll U; Grünwald F; Drzezga A; Spitz J; Poser S
J Neurol; 2002 Jun; 249(6):699-705. PubMed ID: 12111302
[TBL] [Abstract][Full Text] [Related]
6. Multitracer study with positron emission tomography in Creutzfeldt-Jakob disease.
Engler H; Lundberg PO; Ekbom K; Nennesmo I; Nilsson A; Bergström M; Tsukada H; Hartvig P; Långström B
Eur J Nucl Med Mol Imaging; 2003 Jan; 30(1):85-95. PubMed ID: 12483414
[TBL] [Abstract][Full Text] [Related]
7. Positron emission tomography in Creutzfeldt-Jakob disease.
Holthoff VA; Sandmann J; Pawlik G; Schröder R; Heiss WD
Arch Neurol; 1990 Sep; 47(9):1035-8. PubMed ID: 2204331
[TBL] [Abstract][Full Text] [Related]
8. FDG-PET in Creutzfeldt-Jakob disease: Analysis of clinical-PET correlation.
Renard D; Castelnovo G; Collombier L; Thouvenot E; Boudousq V
Prion; 2017 Nov; 11(6):440-453. PubMed ID: 29099286
[TBL] [Abstract][Full Text] [Related]
9. Metabolic Changes Detected by 18F-FDG PET in the Preclinical Stage of Familial Creutzfeldt-Jakob Disease.
Lu H; Jing D; Chen Y; Cui C; Gao R; Wang L; Liang Z; Chen K; Wu L
J Alzheimers Dis; 2020; 77(4):1513-1521. PubMed ID: 32925055
[TBL] [Abstract][Full Text] [Related]
10. Regional cerebral glucose metabolism in major depressive disorder.
Hurwitz TA; Clark C; Murphy E; Klonoff H; Martin WR; Pate BD
Can J Psychiatry; 1990 Nov; 35(8):684-8. PubMed ID: 2282619
[TBL] [Abstract][Full Text] [Related]
11. 18F-fluorodeoxyglucose-PET and 99mTc-bicisate-SPECT in Creutzfeldt-Jakob disease.
Grünwald F; Pohl C; Bender H; Hartmann A; Menzel C; Ruhlmann J; Keller E; Biersack HJ
Ann Nucl Med; 1996 Feb; 10(1):131-4. PubMed ID: 8814717
[TBL] [Abstract][Full Text] [Related]
12. Regional cerebral glucose metabolism and attention in adults with a history of childhood autism.
Siegel BV; Asarnow R; Tanguay P; Call JD; Abel L; Ho A; Lott I; Buchsbaum MS
J Neuropsychiatry Clin Neurosci; 1992; 4(4):406-14. PubMed ID: 1422167
[TBL] [Abstract][Full Text] [Related]
13. Regional cerebral glucose utilization in chronic organic mental disorders associated with alcoholism.
Martin PR; Rio D; Adinoff B; Johnson JL; Bisserbe JC; Rawlings RR; Rohrbaugh JW; Stapleton JM; Eckardt MJ
J Neuropsychiatry Clin Neurosci; 1992; 4(2):159-67. PubMed ID: 1627977
[TBL] [Abstract][Full Text] [Related]
14. Cerebral hypermetabolism demonstrated by FDG PET in familial Creutzfeldt-Jakob disease.
Nagasaka T; Nagasaka K; Ohta E; Shindo K; Takiyama Y; Shiozawa Z; Miyazawa N; Yamasaki N; Mori N; Onda H; Shinohara T
Clin Nucl Med; 2011 Aug; 36(8):725-7. PubMed ID: 21716034
[TBL] [Abstract][Full Text] [Related]
15. Multitracer study in Heidenhain variant of Creutzfeldt-Jakob disease: mismatch pattern of cerebral hypometabolism and perfusion imaging.
Pichler R; Ciovica I; Rachinger J; Weiss S; Aichner FT
Neuro Endocrinol Lett; 2008 Feb; 29(1):67-8. PubMed ID: 18283251
[TBL] [Abstract][Full Text] [Related]
16. Positron tomography demonstrates frontal lobe hypometabolism in progressive supranuclear palsy.
Goffinet AM; De Volder AG; Gillain C; Rectem D; Bol A; Michel C; Cogneau M; Labar D; Laterre C
Ann Neurol; 1989 Feb; 25(2):131-9. PubMed ID: 2784043
[TBL] [Abstract][Full Text] [Related]
17. Glucose metabolism in sporadic Creutzfeldt-Jakob disease: a statistical parametric mapping analysis of (18) F-FDG PET.
Kim EJ; Cho SS; Jeong BH; Kim YS; Seo SW; Na DL; Geschwind MD; Jeong Y
Eur J Neurol; 2012 Mar; 19(3):488-93. PubMed ID: 22050286
[TBL] [Abstract][Full Text] [Related]
18. The metabolic landscape of cortico-basal ganglionic degeneration: regional asymmetries studied with positron emission tomography.
Eidelberg D; Dhawan V; Moeller JR; Sidtis JJ; Ginos JZ; Strother SC; Cederbaum J; Greene P; Fahn S; Powers JM
J Neurol Neurosurg Psychiatry; 1991 Oct; 54(10):856-62. PubMed ID: 1744638
[TBL] [Abstract][Full Text] [Related]
19. Cerebral glucose metabolism in five patients with Lennox-Gastaut syndrome.
Iinuma K; Yanai K; Yanagisawa T; Fueki N; Tada K; Ito M; Matsuzawa T; Ido T
Pediatr Neurol; 1987; 3(1):12-8. PubMed ID: 3149469
[TBL] [Abstract][Full Text] [Related]
20. Amyloid- and FDG-PET in sporadic Creutzfeldt-Jakob disease: Correlation with pathological prion protein in neuropathology.
Matías-Guiu JA; Guerrero-Márquez C; Cabrera-Martín MN; Gómez-Pinedo U; Romeral M; Mayo D; Porta-Etessam J; Moreno-Ramos T; Carreras JL; Matías-Guiu J
Prion; 2017 May; 11(3):205-213. PubMed ID: 28509609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
